Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4-Reference-Cited by-同舟云学术

Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4

Published:2018-03 Issue:3 Volume:30 Page:302-309
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:European Journal of Gastroenterology & Hepatology

Author:

Roulot Dominique,Thibault Vincent,Laforest Claire,Fontaine Hélène,Bronowicki Jean-Pierre,Asselah Tarik,Bourlière Marc,Canva Valérie,Leroy Vincent,Loustaud-Ratti Véronique,Ouzan Denis,Zoulim Fabien,Schischmanoff Olivier,Rousseau Chloé,Renault Alain,Petrov-Sanchez Ventzislava,Diallo Alpha,Bellissant Eric,Serfaty Lawrence

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference37 articles.

1. Global distribution and prevalence of hepatitis C virus genotypes

2. Literature review of the distribution of hepatitis C virus genotypes across Europe

3. Global epidemiology and genotype distribution of the hepatitis C virus infection

4. Hepatitis C Virus Genotype 4 Resistance and Subtype Demographic Characterization of Patients Treated with Ombitasvir plus Paritaprevir/Ritonavir

5. Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antivirals against HCV infection: the story thus far;The Journal of Infection in Developing Countries;2022-02-28

2. Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents;Infection and Drug Resistance;2018-11

3. Comment on ‘Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study’;European Journal of Gastroenterology & Hepatology;2018-07

4. Povital role of platelet count in platelet–lymphocyte count used in distinguishing patients with significant liver fibrosis and insulin resistance;European Journal of Gastroenterology & Hepatology;2018-07